HIV drug and supply stock-outs in Latin America

Simple item page
dc.contributor.authorSued, Omar
dc.contributor.authorSchreiber, Claudia
dc.contributor.authorGirón, Nicolas
dc.contributor.authorGhidinelli, Marcelo
dc.date.accessioned2024-05-23T18:53:33Z
dc.date.available2024-05-23T18:53:33Z
dc.date.issued2011
dc.description.abstractWhen stocks of HIV drugs and supplies run out, unplanned treatment interruptions lead to increased risk of HIV drug resistance, treatment failure, and death.1 In the early days of antiretroviral therapy (ART) programmes, management of HIV supplies outside of national systems was considered acceptable by governments to facilitate scale-up2, but this approach is proving difficult to sustain. In May, 2011, the Pan American Health Organization (the regional office for the Americas of WHO) undertook a survey of national AIDS programmes in 12 countries to characterise stock-outs or episodes where there was a risk of stock-out affecting antiretroviral HIV supplies in Latin America
dc.identifier.citationSued, O., Schreiber, C., Girón, N., & Ghidinelli, M. (2011). HIV drug and supply stock-outs in Latin America. The Lancet Infectious Diseases.
dc.identifier.otherDOI: 10.1016/S1473-3099(11)70301-2
dc.identifier.urihttps://repositorio.huesped.org.ar/handle/123456789/1096
dc.relation.ispartofseriesThe Lancet Infectious Diseases
dc.subjectHIV drug
dc.subjectsupply stock-outs
dc.subjectLatin America
dc.titleHIV drug and supply stock-outs in Latin America

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
144_2011_ Sued_HIV drug and supply stock-outs in Latin America.pdf
Size:
43.77 KB
Format:
Adobe Portable Document Format
Download

Collections

Articulos científicos